Description
GLP-2 R (Tirz) is a dual-acting research peptide developed to engage both the GLP-1 and GIP receptors, two key pathways involved in metabolic regulation and energy balance. By targeting these complementary signaling systems, Tirz has become a central focus in advanced metabolic and obesity-related research.
Ongoing investigations suggest that dual-agonist signaling may offer enhanced metabolic efficiency compared to single-pathway compounds. This synergistic approach has positioned Tirz as an important comparative compound in next-generation metabolic studies.
